Search for: "Roche Pharmaceuticals Inc."
Results 81 - 100
of 222
Sort by Relevance
|
Sort by Date
17 Aug 2011, 3:00 pm
Endo Pharmaceuticals, Inc., C.A. [read post]
14 Aug 2011, 9:11 am
., Inc., 509 U.S. 579 (1993). [read post]
25 Jul 2011, 10:48 am
., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets, Warner Chilcott, LLC; BONIVA (ibandronate sodium) tablets and injection, Roche Therapeutics, Inc.; RECLAST (zoledronic acid) injection, Novartis Pharmaceuticals Corp.; and the generic equivalents for these products, if any. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
22 Jun 2011, 7:09 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s… [read post]
22 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., holding that the Bayh-Dole Act does not automatically vest title of federally funded inventions to federal contractors (e.g., universities). [read post]
22 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., holding that the Bayh-Dole Act does not automatically vest title of federally funded inventions to federal contractors (e.g., universities). [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
14 Jun 2011, 9:24 pm
• Defendants: Mylan Inc.; Mylan Pharmaceuticals, Inc. [read post]
7 Jun 2011, 9:18 am
Roche Molecular Systems, Inc. [read post]
6 Jun 2011, 2:00 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
7 Apr 2011, 1:16 pm
Hoffman-La Roche, Inc., 1981 U.S. [read post]
23 Mar 2011, 1:30 pm
The drug is jointly developed by Genentech Inc., a member of the Roche group, under an agreement with Novartis Pharma AG. [read post]
22 Mar 2011, 4:21 pm
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
1 Mar 2011, 10:13 am
Roche Molecular Systems, Inc., argued February 28, 2011, presents a classic conflict between text and policy. [read post]
28 Feb 2011, 8:19 am
Hoffmann-La Roche Inc., 541 F.3d 1115, 1122 (Fed. [read post]
28 Feb 2011, 8:19 am
Hoffmann-La Roche Inc., 541 F.3d 1115, 1122 (Fed. [read post]
